For research updates, follow us on:
Independent institutional research identifying structural risk and asymmetric downside in small and micro-cap equities.
– RTB Digital (RTB) is up 300% over the past month on hype and momentum, but no metrics for revenue projections. – From the analysis of semrush.com, RTB’s crypto-media website,
Pulse Biosciences (PLSE) is a medical device company with one product, called the CellFX system, which delivers nanosecond
Rego Payment Architectures’ (RPMT) flagship product is app Mazoola, a financial program for families. RPMT’s revenue has been
Greenwich LifeSciences (GLSI) is a pre-revenue biotech that has only one experimental drug in its pipeline, GP2, which
Know Labs (KNW) is a blatant and obvious medical device scam, claiming to be able to non-invasively measure
Sabizabulin’s mechanism of action doesn’t make sense to treat Covid. Veru already had a relationship with the centers
We believe there is a likely scenario of the FDA delaying approval or outright rejecting the EUA application
